Idiosyncratic drug reactions: the reactive metabolite syndromes.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The Lancet

• Publication date

  2000-11-04

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0140-6736(00)03137-8PMID 11075787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate.

  1999cited by this paper
• New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system.

  1999cited by this paper
• Lamotrigine-associated anticonvulsant hypersensitivity syndrome

  1998cited by this paper
• Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis.

  1998cited by this paper
• Free Radical Intermediates of Phenytoin and Related Teratogens

  1998cited by this paper
• Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective.

  1998cited by this paper
• Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

  1998cited by this paper
• Minocycline-induced lupus in adolescents.

  1998cited by this paper
• Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study

  1997cited by this paper
• In vivo and in vitro testing for adverse drug reactions.

  1997cited by this paper
• Advances in the Treatment and Prophylaxis of Pneumocystis carinii Pneumonia

  1997cited by this paper
• Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation.

  1997cited by this paper
• Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.

  1996cited by this paper
• Antinuclear and antinucleolar antibodies in patients with scleroderma-polymyositis overlap syndrome.

  1996cited by this paper
• Antineutrophil cytoplasmic antibody-positive polyarthritis associated with minocycline therapy.

  1996cited by this paper
• Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

  1996cited by this paper
• Drug-induced hepatotoxicity.

  1996cited by this paper
• Cefaclor serum sickness.

  1996cited by this paper
• Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

  1996cited by this paper
• Minocycline related lupus.

  1996cited by this paper
• Carbamazepine‐induced drug rashes: diagnostic value of patch tests depends on clinico‐pathologic presentation

  1996cited by this paper
• Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature.

  1996cited by this paper
• Management of acquired bullous skin diseases.

  1995cited by this paper
• Severe adverse cutaneous reactions to drugs.

  1995cited by this paper
• Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity.

  1995cited by this paper
• Anticonvulsant hypersensitivity syndrome.

  1995cited by this paper
• Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

  1995cited by this paper
• Effectiveness of early therapy with corticosteroids in Stevens-Johnson syndrome: experience with 41 cases and a hypothesis regarding pathogenesis.

  1994cited by this paper
• Drug-induced lupus.

  1994cited by this paper
• Severe adverse cutaneous reactions to drugs.

  1994cited by this paper
• Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions.

  1994cited by this paper
• Serum sickness-like reactions associated with cefprozil therapy.

  1994cited by this paper
• Safety of Lamotrigine

  1994cited by this paper
• Treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome in children.

  1993cited by this paper
• Programmed cell death, apoptosis and killer genes.

  1993cited by this paper
• Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.

  1993cited by this paper
• Drug‐induced hypothyroidism: The thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides

  1992cited by this paper
• Minocycline-related lupus.

  1992cited by this paper
• Sulfamethoxazole is metabolized to the hydroxylamine in humans

  1992cited by this paper
• Cefaclor-Associated Serum Sickness-Like Disease: Eight Cases and Review of the Literature

  1992cited by this paper
• Familial occurrence of hypersensitivity to phenytoin.

  1991cited by this paper
• In-vitro assessment of a hypersensitivity syndrome associated with sorbinil.

  1991cited by this paper
• Serum sickness in children after antibiotic exposure: estimates of occurrence and morbidity in a health maintenance organization population.

  1990cited by this paper
• Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.

  1990cited by this paper
• Drug-related lupus.

  1989cited by this paper
• Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (Augmentin)

  1989cited by this paper
• Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.

  1989cited by this paper
• Drug-related lupus.

  1988cited by this paper
• Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.

  1988cited by this paper
• A prospective clinical and immunologic analysis of patients with serum sickness.

  1984cited by this paper
• Drug-induced lupus

  1982cited by this paper
• Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool.

  1982cited by this paper
• Anticonvulsant toxicity in vitro: possible role of arene oxides.

  1981cited by this paper
• High incidence of a concentration-dependent skin reaction in children treated with phenytoin.

  1978cited by this paper

• Anti‐Tubercular Drug‐Induced Liver Injury: Current Understanding and Emerging Directions

  2026cites this paper
• A comprehensive update on the human leukocyte antigen and idiosyncratic adverse drug reactions

  2025cites this paper
• NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort

  2025cites this paper
• Rare presentation of drug-induced oral erythema multiforme and its management: a case report

  2024cites this paper
• Insights gained into the injury mechanism of drug and herb induced liver injury in the hepatic microenvironment.

  2024cites this paper
• Clinical characteristics and genetic HLA marker for patients with oxaliplatin-induced adverse drug reactions.

  2024cites this paper
• Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury

  2024cites this paper
• Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI

  2023cites this paper
• Novel insights into molecular and cellular aspects of delayed drug hypersensitivity reactions

  2023cites this paper
• @Western Scholarship@Western

  2022cites this paper
• The role of in vitro testing in pharmacovigilance for ß-lactam-induced serum sickness-like reaction: A pilot study

  2022cites this paper
• Advances in the Pathomechanisms of Delayed Drug Hypersensitivity.

  2022cites this paper
• Anti-tuberculosis Drug Induced Hepatotoxicity

  2022cites this paper
• Genetic markers of drug hypersensitivity in pediatrics: current state and promise

  2022cites this paper
• Pathophysiology of drug hypersensitivity

  2022cites this paper
• Antioxidant-Based Preventive Effect of Phytochemicals on Anticancer Drug-Induced Hepatotoxicity

  2022cites this paper
• Plant extracts with putative hepatotoxicity activity

  2021cites this paper
• Relationship between xanthine oxidase gene polymorphisms and anti-tuberculosis drug-induced liver injury in a Chinese population.

  2021cites this paper
• Stability Indicating RP-HPLC Method for the Analysis of Dacomitinib and its Related Impurities in Bulk and Oral Solid Dosage Formulations

  2021cites this paper
• Serum Sickness Like Disease in Children

  2021cites this paper
• Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?

  2021cites this paper
• Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice

  2021cites this paper
• Serum soluble Fas ligand levels and peripheral blood lymphocyte subsets in patients with drug-induced maculopapular rashes, dress, and viral exanthemas.

  2020cites this paper
• In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling

  2020cites this paper
• Toxic epidermal necrolysis

  2020cites this paper
• Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach

  2020cites this paper
• A Patient with Acute Liver Injury after Sulfamethoxazole/Trimethoprim Treatment for Pyelonephritis

  2020cites this paper
• Site-Level Bioactivity of Small-Molecules from Deep-Learned Representations of Quantum Chemistry.

  2020cites this paper
• Phase I metabolic profiling and unexpected reactive metabolites in human liver microsome incubations of X-376 using LC-MS/MS: bioactivation pathway elucidation and in silico toxicity studies of its metabolites

  2020cites this paper
• DRESS syndrome: an important differential for eosinophilia with systemic organ dysfunction

  2020cites this paper
• Identification of Iminium Intermediates Generation in the Metabolism of Tepotinib Using LC-MS/MS: In Silico and Practical Approaches to Bioactivation Pathway Elucidation

  2020cites this paper
• Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine

  2020cites this paper
• Impact of the host environment on the antitubercular action of pyrazinamide

  2019cites this paper
• Pengaruh Pemberian Curcumin Terhadap Konversi Sputum pada Pasien Tuberkulosis Dalam Pengobatan Kategori 1 Fase Intensif

  2019cites this paper
• Reactive intermediates and bioactivation pathways characterization of avitinib by LC–MS/MS: In vitro metabolic investigation

  2019cites this paper
• Drug-induced liver injury

  2019cites this paper
• Chemotherapy-Induced Peripheral Neuropathy.

  2019cites this paper
• Effect of Methanol Extract of Gomphrena celesioides on Chloroquine-Induced Hepatotoxicity and Oxidative Stress in Male Wistar Rats

  2019cites this paper
• A Time-Embedding Network Models the Ontogeny of 23 Hepatic Drug Metabolizing Enzymes.

  2019cites this paper
• Reactive intermediates in naquotinib metabolism identified by liquid chromatography-tandem mass spectrometry: phase I metabolic profiling

  2019cites this paper
• Belizatinib: Novel reactive intermediates and bioactivation pathways characterized by LC-MS/MS.

  2019cites this paper
• Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides

  2019cites this paper
• Detection and characterization of olmutinib reactive metabolites by LC-MS/MS: Elucidation of bioactivation pathways.

  2019cites this paper
• Treatment of Drug-Induced Erythema Multiforme: Case Report

  2019cites this paper
• Liquid chromatography–tandem mass spectrometry metabolic profiling of nazartinib reveals the formation of unexpected reactive metabolites

  2019cites this paper
• Sapitinib: reactive intermediates and bioactivation pathways characterized by LC-MS/MS

  2019cites this paper
• The Low Risks and High Rewards of Penicillin Allergy Delabeling: An Algorithm to Expedite the Evaluation.

  2019cites this paper
• Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC–MS/MS: in vitro metabolic investigation

  2019cites this paper
• The A/A Genotype of XPO1 rs4430924 Is Associated With Higher Risk of Antituberculosis Drug‐Induced Hepatotoxicity in Chinese Patients

  2019cites this paper
• UHPLC-MS/MS method for simultaneous determination of carbamazepine and its seven major metabolites in serum of epileptic patients.

  2019cites this paper
• Reactive intermediates in copanlisib metabolism identified by LC-MS/MS: phase I metabolic profiling

  2019cites this paper
• In silico prediction of drug-induced liver injury: Quo vadis?

  2019cites this paper
• LC-MS/MS reveals the formation of reactive ortho-quinone and iminium intermediates in saracatinib metabolism: Phase I metabolic profiling.

  2018cites this paper
• Hepatotoxicity: Its Mechanisms, Experimental Evaluation and Protective Strategies

  2018cites this paper
• Importance of hypersensitivity in adverse reactions to drugs in the elderly

  2018cites this paper
• Practical Approach to Diagnosis and Management of Cutaneous Adverse Drug Reactions

  2018cites this paper
• Today's Challenges to De-Risk and Predict Drug Safety in Human "Mind-the-Gap".

  2018cites this paper
• Interplay of gender, age and drug properties on reporting frequency of drug‐induced liver injury

  2018cites this paper
• RY Frequency of Postoperative Fever in Children with Congenital Heart Disease Undergoing Cardiovascular Surgery and Associated Risk Factors

  2018cites this paper
• Demographic and clinical characteristics of patients with serum sickness-like reaction

  2018cites this paper
• Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

  2018cites this paper
• DRESS syndrome: a detailed insight

  2018cites this paper
• Generation and characterization of dapsone- and nitroso-dapsone-specific T-cells: an insight into the molecular pathomechanism of dapsone hypersensitivity syndrome.

  2018cites this paper
• Drug-Induced Liver Injury—Perspectives from Pathology

  2018cites this paper
• Evaluation of the Relevance of DILI Predictive Hypotheses in Early Drug Development: Review of In Vitro Methodologies vs BDDCS Classification.

  2018cites this paper
• LC–MS/MS reveals the formation of iminium and quinone methide reactive intermediates in entrectinib metabolism: In vivo and in vitro metabolic investigation

  2018cites this paper
• Characterization of reactive intermediates formation in dacomitinib metabolism and bioactivation pathways elucidation by LC-MS/MS: in vitro phase I metabolic investigation

  2018cites this paper
• Role of cytochrome P450-mediated metabolism and involvement of reactive metabolite formations on antiepileptic drug-induced liver injuries.

  2018cites this paper
• Pharmacogenetics of Adverse Drug Reactions.

  2018cites this paper
• LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways

  2018cites this paper
• Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC–ESI–MS/MS

  2018cites this paper
• Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment

  2018cites this paper
• Evaluation of DILI Predictive Hypotheses in Early Drug Development.

  2017cites this paper
• “Autoimmune(-Like)” Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis

  2017cites this paper
• Adverse Medication Reactions

  2017cites this paper
• Metabolomic approaches in the discovery of potential urinary biomarkers of drug-induced liver injury (DILI)

  2017cites this paper
• An algorithmic model to renew infected liver volumes

  2017cites this paper
• In vitro μοντέλο για εκτίμηση της ηπατοτοξικότητας από φάρμακα

  2017cites this paper
• Diphenhydramine as a Cause of Drug-Induced Liver Injury

  2017cites this paper
• LC-MS/MS reveals the formation of aldehydes and iminium reactive intermediates in foretinib metabolism: phase I metabolic profiling

  2017cites this paper
• Presumed serum sickness following thymoglobulin treatment of acute cellular rejection of a cardiac allograft.

  2017cites this paper
• Deep Learning to Predict the Formation of Quinone Species in Drug Metabolism.

  2017cites this paper
• Urgent Living-Donor Liver Transplantation in a Patient With Concurrent Active Tuberculosis: A Case Report.

  2016cites this paper
• Pharmacogenetics in Gastroenterology

  2016cites this paper
• Special endpoint and product specific considerations in pharmaceutical acceptable daily exposure derivation.

  2016cites this paper
• Altération de la dynamique des canalicules biliaires in vitro : une nouvelle approche de la prédiction de la cholestase intrahépatique d'origine médicamenteuse

  2016cites this paper
• Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases

  2016cites this paper
• History repeats itself: the family medication history and pharmacogenomics.

  2016cites this paper
• An 82-year-old man with ataxia and dysarthria

  2016cites this paper
• The mechanism and risk factors of clopidogrel-induced liver injury

  2016cites this paper
• Systems biology approaches for identifying adverse drug reactions and elucidating their underlying biological mechanisms

  2016influential citation
• In Vitro Methods in Immunotoxicity Assessment

  2016cites this paper
• Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network

  2016cites this paper
• HLA and Delayed Drug-Induced Hypersensitivity

  2016cites this paper
• Drug-induced liver injury: Interactions between drug properties and host factors.

  2015cites this paper
• Fundamental Study of Improving an Efficient Assay in Patient of Drug-induced Allergy: ― Kinetic Analysis of Cell Mobility as a Primary Screening Method ―@@@― 1次スクリーニングとしての細胞動態解析 ―

  2015cites this paper
• Plant Pharmacogenomics: From Drug Discovery to Personalized Ethnomedicine

  2015cites this paper
• Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network

  2015cites this paper
• Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione.

  2015cites this paper
• Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury.

  2015cites this paper